Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-18-047750
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-21 16:24:02
Reporting Period:
2018-08-20
Accepted Time:
2018-08-21 16:24:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1403708 Evoke Pharma Inc EVOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201886 F Patrick Latterell 2603 Camino Ramon
Suite 200
San Ramon CA 94583-4289
No No Yes No
1332654 L.p. Iii Ventures Science Life Lvp 2603 Camino Ramon
Suite 200
San Ramon CA 94583-4289
No No Yes No
1341508 Lvp Iii Associates, L.p. 2603 Camino Ramon
Suite 200
San Ramon CA 94583-4289
No No Yes No
1384618 Lvp Iii Partners Lp 2603 Camino Ramon
Suite 200
San Ramon CA 94583-4289
No No Yes No
1581469 Lvp Gp Iii, Llc 2603 Camino Ramon
Suite 200
San Ramon CA 94583-4289
No No Yes No
1581471 Lvpmc, Llc 2603 Camino Ramon
Suite 200
San Ramon CA 94583-4289
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-20 465,116 $2.35 1,937,983 No 4 P Indirect Directly owned by LVP III
Common Stock Acquisiton 2018-08-20 23,256 $2.35 96,897 No 4 P Indirect Directly owned by Associates
Common Stock Acquisiton 2018-08-20 11,628 $2.35 48,449 No 4 P Indirect Directly owned by Partners
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Directly owned by LVP III
No 4 P Indirect Directly owned by Associates
No 4 P Indirect Directly owned by Partners
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,250 Indirect Directly owned by LVPMC
Footnotes
  1. The reported securities are owned directly by each of LVPMC, LLC ("LVPMC"), LVP Life Science Ventures III, L.P. ("LVP III"), LVP III Associates, L.P. ("Associates") and LVP III Partners, L.P. ("Partners"). LVP GP III, LLC ("GP III") is the general partner of LVP III, Associates and Partners. GP III may be deemed to have sole voting power and dispositive power over the shares held by LVP III, Associates and Partners. Each of GP III and Patrick Latterell, the managing member of GP III and the manager of LVPMC, may be deemed to share voting and dispositive power over the reported securities and disclaim beneficial ownership of the reported securities held by LVPMC, LVP III, Associates and Partners except to the extent of any pecuniary interest therein.